BioWorld

March 7, 2003

View Archived Issues

Mice Sans Cytochrome Gene Have Ocular Drainage Irregularities That Mimic Human Congenital Glaucoma

Interleukin Cedes Majority Interest To Alticor Through Collaboration

Northfield Gets FDA Approval For Phase III Trial Of PolyHeme

PanCel Gets Telomerase License From Geron For Diabetes Program

Other News To Note

Correction

U.S. Patent Disclosures

FDA Head Says Administration Has Hatch-Waxman Under Control

WASHINGTON - FDA Commissioner Mark McClellan told a House subcommittee Thursday that legislation to close loopholes in the Hatch-Waxman Act is not necessary. (BioWorld Today) Read More

ImClone Receives $60M Payment As Part Of Revamped BMS Deal

Today's news in brief

BioWorld

BioWorld briefs for June 16, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Medical illustration showing layers of a blood vessel

Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis

BioWorld Science

More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...

Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

BioWorld Science

Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...